Literature DB >> 3872215

Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus.

J P Coutelier, J Van Snick.   

Abstract

Lactic dehydrogenase elevating virus (LDV) was found to selectively stimulate IgG2a synthesis in infected mice. Within one week after infection, the production of IgG2a increased nearly 50-fold whereas that of IgM, IgA, IgG1 and IgG3 remained virtually unchanged. IgG2b synthesis was also enhanced but to a lesser extent. Several observations suggested that this stimulation of IgG2 production resulted from a polyclonal B cell activation: (a) the isoelectric focusing patterns of IgG2a before and after LDV infection were exactly the same, (b) the frequency of clones with anti-LDV activity in hybridoma collections derived from infected mice was extremely low (less than 4/1000) and (c) the proliferative response elicited by LDV in unsensitized animals was comparable with that induced by lipopolysaccharide. The effect of LDV on immunoglobulin synthesis was drastically reduced in nude mice but was not affected by the X-linked B lymphocyte defect of animals carrying the xid mutation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872215     DOI: 10.1002/eji.1830150308

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  25 in total

1.  Identification of NAD+ synthetase from Streptococcus sobrinus as a B-cell-stimulatory protein.

Authors:  Isabel Veiga-Malta; Margarida Duarte; Márcia Dinis; Pedro Madureira; Paula Ferreira; Arnaldo Videira
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

2.  Protective effect of a T-cell-dependent immunosuppressive, B-cell-mitogenic protein (F3'EP-Si, or P90) produced by Streptococcus intermedius.

Authors:  M Lima; A Bandeira; D Portnoi; A Ribeiro; M A Chaves
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

3.  Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages.

Authors:  S Léonard; I Pierard; T E Michaelsen; S Izui; P L Masson; J-P Coutelier
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 4.  Interactions of viruses with the immune system.

Authors:  C A Mims
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

5.  Poliomyelitis in MuLV-infected ICR-SCID mice after injection of basement membrane matrix contaminated with lactate dehydrogenase-elevating virus.

Authors:  Jodi A Carlson Scholz; Rohit Garg; Susan R Compton; Heather G Allore; Caroline J Zeiss; Edward M Uchio
Journal:  Comp Med       Date:  2011-10       Impact factor: 0.982

6.  Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.

Authors:  Shelly J Robertson; Christoph G Ammann; Ronald J Messer; Aaron B Carmody; Lara Myers; Ulf Dittmer; Savita Nair; Nicole Gerlach; Leonard H Evans; William A Cafruny; Kim J Hasenkrug
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

7.  The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation.

Authors:  Sarah E Blutt; Sue E Crawford; Kelly L Warfield; Dorothy E Lewis; Mary K Estes; Margaret E Conner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host.

Authors:  D Tavares; A Salvador; P Ferreira; M Arala-Chaves
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Antibody production and blastogenic response in pigs experimentally infected with porcine reproductive and respiratory syndrome virus.

Authors:  S A Vézina; H Loemba; M Fournier; S Dea; D Archambault
Journal:  Can J Vet Res       Date:  1996-04       Impact factor: 1.310

10.  Interleukin-12 gene expression after viral infection in the mouse.

Authors:  J P Coutelier; J Van Broeck; S F Wolf
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.